How to Handle "Saleable Returns" Under New FDA Verification Guidelines

Handling saleable returns has become more structured and accountable under updated regulatory expectations. For pharmaceutical distributors, the process now requires tighter verification, better documentation, and a clear system for tracking returned products before they re-enter the supply chain.

This blog explains how to manage saleable returns properly while staying compliant with the latest FDA verification requirements.

What Are Saleable Returns?

Saleable returns are prescription drug products that:

• Have been returned by a downstream trading partner (pharmacy, hospital, etc.)
• Are in good condition
• Can be resold after proper verification

However, not every returned product qualifies. The FDA requires distributors to verify each returned product before resale to ensure patient safety and prevent counterfeit drugs from entering the supply chain.

Understanding FDA Verification Requirements

Under the guidelines of the U.S. Food and Drug Administration, aligned with the Drug Supply Chain Security Act (DSCSA), distributors must verify returned products at the package level.

This includes checking:

• Product identifier (PI)
• National Drug Code (NDC)
• Serial number
• Lot number
• Expiration date

If a product cannot be verified, it must not be resold.

Step-by-Step Process to Handle Saleable Returns

1. Receive and Segregate Returns

When a product is returned:

• Separate it from regular inventory
• Label it clearly as “Returned – Pending Verification”
• Store it under proper conditions

This step ensures that unverified products are not accidentally reintroduced into circulation.

2. Inspect Physical Condition

Before verification, check:

• Packaging integrity
• Signs of tampering
• Expiry status
• Storage conditions, especially for temperature-sensitive products

If the product shows any sign of damage or compromise, it should be rejected immediately.

3. Verify Product Identifier (PI)

Verification is the most critical step in the process.

Distributors must:

• Scan the 2D barcode
• Match the data with manufacturer records
• Confirm authenticity using verification systems

Key elements to verify include:

• Correct serial number
• Matching NDC
• Valid lot number and expiry date

4. Use Authorized Verification Systems

Verification should be carried out using:

• Manufacturer databases
• Third-party verification platforms
• Integrated track-and-trace systems

Manual processes are not reliable for compliance at scale and can increase the risk of errors.

5. Maintain Proper Documentation

Every verified return must be recorded accurately.

Important records include:

• Verification results
• Transaction history
• Return logs
• Exception reports

Proper documentation helps during inspections and audits.

6. Decide: Restock or Reject

After verification:

If verified successfully:

• The product can be returned to saleable inventory

If verification fails:

• Mark the product as non-saleable
• Investigate discrepancies
• Report issues when required

Common Challenges in Saleable Returns

Managing saleable returns can present several challenges:

• Unreadable or missing barcodes
• Incomplete transaction information
• Delayed responses from manufacturers
• Lack of system integration
• Insufficient staff training

These challenges can lead to compliance gaps if not addressed properly.

Best Practices for Compliance

Standard Operating Procedures (SOPs)

• Establish clear workflows for handling returns
• Include defined verification steps
• Ensure procedures are updated regularly

Invest in Technology

• Use barcode scanning systems
• Implement track-and-trace platforms
• Automate verification processes where possible

Staff Training

• Train employees on DSCSA and FDA requirements
• Conduct regular training sessions

Vendor Coordination

• Maintain strong communication with manufacturers
• Ensure quick access to verification data

Audit Preparedness

• Keep records well-organized
• Conduct periodic internal audits

Role of Pharmaceutical Distribution Companies

For pharmaceutical distribution companies, handling saleable returns is a critical responsibility. It directly affects:

• Patient safety
• Regulatory compliance
• Operational efficiency
• Business reputation

Distributors serve as a key checkpoint in ensuring that only safe and verified products are made available in the market.

How Technology Supports Saleable Returns

Technology plays a significant role in simplifying compliance:

• Real-time barcode scanning improves accuracy
• Automated alerts help detect mismatches
• Centralized systems store and manage data efficiently
• Faster communication channels reduce delays

This reduces manual effort and improves overall process reliability.

Regulatory Risks of Non-Compliance

Failure to comply with FDA verification requirements can result in:

• Product recalls
• Financial penalties
• Suspension of operations
• Loss of trust among partners and customers

Even a single lapse can have serious consequences.

Future Outlook

As regulations continue to evolve:

• Electronic interoperability will become standard
• Real-time verification will be expected across the supply chain
• Manual systems will become less relevant

Distributors should proactively upgrade systems and refine processes to stay compliant.

Conclusion

Handling saleable returns under FDA guidelines requires a structured approach, supported by proper systems and trained personnel. Each step, from receiving returned goods to final verification, must be handled with accuracy and care.

Businesses working with reliable pharmaceutical distribution companies are better equipped to manage these requirements efficiently.

Drugzone supports safe and compliant distribution practices by focusing on quality handling, proper verification processes, and adherence to regulatory standards. Their approach helps ensure that only verified products re-enter the supply chain, contributing to patient safety and trust within the healthcare ecosystem.

FAQs

1. What happens if a returned product cannot be verified?

If a product cannot be verified, it must be classified as non-saleable and should not be reintroduced into the supply chain.

2. Is manual checking enough for saleable returns verification?

No, manual checking alone is not sufficient. FDA guidelines require electronic verification systems to ensure accuracy and compliance.

3. Who is responsible for verifying saleable returns?

Wholesale distributors are responsible for verifying returned products before they are restocked or resold.

Article Author

Binu .B RPH

President

With more than 20 years of experience in the pharmaceutical wholesale sector, I have Founded and managed several companies, including a pharmaceutical wholesale company, a compounding/retail pharmacy,and many more. As the president of Drugzone Pharmaceuticals Inc., I develop new business and maintain existing business relationships.